These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 3334987

  • 1. Interactions of putative estrogens with the intracellular receptor complex in mouse Leydig cells: relationship to preneoplastic hyperplasia.
    Juriansz RL, Huseby RA, Wilcox RB.
    Cancer Res; 1988 Jan 01; 48(1):14-8. PubMed ID: 3334987
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. DNA synthesis and DNA polymerase activity in Leydig cells of diethylstilbestrol-stimulated mouse testes.
    Spruance SL, Wilcox B, Richards OC, Foster DN, Huseby RA, Samuels LT.
    Cancer Res; 1978 Feb 01; 38(2):424-30. PubMed ID: 620411
    [Abstract] [Full Text] [Related]

  • 4. Increase in testis luteinizing hormone receptor by estrogen in mice susceptible to Leydig cell tumors.
    Navickis RJ, Shimkin MB, Hsueh AJ.
    Cancer Res; 1981 May 01; 41(5):1646-51. PubMed ID: 6260347
    [Abstract] [Full Text] [Related]

  • 5. Changes in fine structure accompanying estrogen-induced tumorigenesis of Leydig cells in the mouse testis.
    Kurland G, Christensen AK, Huseby RA.
    Cancer Res; 1975 Jul 01; 35(7):1671-86. PubMed ID: 236824
    [Abstract] [Full Text] [Related]

  • 6. Demonstration of a direct carcinogenic effect of estradiol on Leydig cells of the mouse.
    Huseby RA.
    Cancer Res; 1980 Apr 01; 40(4):1006-13. PubMed ID: 7357531
    [Abstract] [Full Text] [Related]

  • 7. Leydig cell hyperplasia in fetal mice treated transplacentally with ethinyl estradiol.
    Yasuda Y, Konishi H, Tanimura T.
    Teratology; 1986 Jun 01; 33(3):281-8. PubMed ID: 2874623
    [Abstract] [Full Text] [Related]

  • 8. Estrogen-induced Leydig cell tumor in the mouse: a model system for the study of carcinogenesis and hormone dependency.
    Huseby RA.
    J Toxicol Environ Health Suppl; 1976 Jun 01; 1():177-92. PubMed ID: 11351
    [Abstract] [Full Text] [Related]

  • 9. Steroid receptor forms and their interaction with cytoplasmic modulators.
    Sato B, Nishizawa Y, Maeda Y, Noma K, Honma T, Matsumoto K.
    J Steroid Biochem; 1983 Jul 01; 19(1A):315-21. PubMed ID: 6887866
    [Abstract] [Full Text] [Related]

  • 10. The testicular estrogen receptor system in two strains of mice differing in susceptibility to estrogen-induced Leydig cell tumors.
    Sato B, Spomer W, Huseby RA, Samuels LT.
    Endocrinology; 1979 Mar 01; 104(3):822-31. PubMed ID: 436739
    [Abstract] [Full Text] [Related]

  • 11. Effects of tamoxifen on estrogen-induced enhancement or inhibition of tumor growth in mouse Leydig cell tumor lines.
    Sato B, Maeda Y, Nishizawa Y, Noma K, Kishimoto S, Matsumoto K.
    Cancer Res; 1984 Oct 01; 44(10):4386-91. PubMed ID: 6467199
    [Abstract] [Full Text] [Related]

  • 12. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
    Trachtenberg J, Hicks LL, Walsh PC.
    J Clin Invest; 1980 May 01; 65(5):1051-9. PubMed ID: 6154062
    [Abstract] [Full Text] [Related]

  • 13. Carcinogenic activities of various steroidal and nonsteroidal estrogens in the hamster kidney: relation to hormonal activity and cell proliferation.
    Li JJ, Li SA, Oberley TD, Parsons JA.
    Cancer Res; 1995 Oct 01; 55(19):4347-51. PubMed ID: 7671246
    [Abstract] [Full Text] [Related]

  • 14. Effect of a dopamine agonist on the development of Leydig cell hyperplasia in Sprague-Dawley rats.
    Dirami G, Teerds KJ, Cooke BA.
    Toxicol Appl Pharmacol; 1996 Nov 01; 141(1):169-77. PubMed ID: 8917689
    [Abstract] [Full Text] [Related]

  • 15. Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney.
    Li JJ, Li SA, Klicka JK, Parsons JA, Lam LK.
    Cancer Res; 1983 Nov 01; 43(11):5200-4. PubMed ID: 6616455
    [Abstract] [Full Text] [Related]

  • 16. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.
    Katzenellenbogen BS, Kendra KL, Norman MJ, Berthois Y.
    Cancer Res; 1987 Aug 15; 47(16):4355-60. PubMed ID: 3607768
    [Abstract] [Full Text] [Related]

  • 17. Dormancy versus extinction of mouse Leydig cell tumors following endocrine-induced regression.
    Huseby RA.
    Cancer Res; 1983 Nov 15; 43(11):5365-78. PubMed ID: 6616470
    [Abstract] [Full Text] [Related]

  • 18. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC, Katzenellenbogen BS, Bindal RD, Katzenellenbogen JA.
    Cancer Res; 1984 Jun 15; 44(6):2302-8. PubMed ID: 6547074
    [Abstract] [Full Text] [Related]

  • 19. Induction of an estrogen-dependent early steroidogenic lesion in murine Leydig tumor cells.
    Zimniski SJ, Melner MH, Puett D.
    Endocrinology; 1985 Jun 15; 116(6):2583-91. PubMed ID: 3996327
    [Abstract] [Full Text] [Related]

  • 20. Effect of a dopamine agonist on luteinizing hormone receptors, cyclic AMP production and steroidogenesis in rat Leydig cells.
    Dirami G, Cooke BA.
    Toxicol Appl Pharmacol; 1998 Jun 15; 150(2):393-401. PubMed ID: 9653071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.